Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sven Perner

Showing results (121-130 of 296) with videos related to

Pageof 30
Sort By:
International Journal of Molecular Sciences|August 6, 2020
NR2F6 as a Prognostic Biomarker in HNSCCLuise Klapper, Julika Ribbat-Idel, Patrick Kuppler, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 2013
Activation of invariant NK T cells in periodontitis lesionsMichael Nowak, Benjamin Krämer, Manuela Haupt, et al.
International Journal of Molecular Sciences|December 28, 2016
Implication of the Receptor Tyrosine Kinase AXL in Head and Neck Cancer ProgressionAnne von Mässenhausen, Johannes Brägelmann, Hannah Billig, et al.
Journal of Personalized Medicine|June 24, 2022
TRIM24 Expression as an Independent Biomarker for Prognosis and Tumor Recurrence in HNSCCLuise Klapper, Christian Idel, Patrick Kuppler, et al.
Histology and Histopathology|July 6, 2023
TRIM11 expression in non-small cell lung cancer is associated with poor prognosisChristiane Kuempers, Tobias Jagomast, Finn-Ole Paulsen, et al.
Rare Tumors|October 31, 2017
Mammary analogue secretory carcinoma of salivary glands: diagnostic pitfall with distinct immunohistochemical profile and molecular featuresOliver Bissinger, Carolin Götz, Andreas Kolk, et al.
Frontiers in Medicine|February 15, 2021
Immunologic "Cold" Squamous Cell Carcinomas of the Head and Neck Are Associated With an Unfavorable PrognosisJulika Ribbat-Idel, Sven Perner, Patrick Kuppler, et al.
International Journal of Molecular Sciences|August 6, 2020
CDK19 as a Potential HPV-Independent Biomarker for Recurrent Disease in HNSCCFinn-Ole Paulsen, Christian Idel, Julika Ribbat-Idel, et al.
Virchows Archiv : an International Journal of Pathology|December 2, 2019
Tumor budding as a prognostic factor in pancreatic ductal adenocarcinomaEkaterina Petrova, Verena Zielinski, Louisa Bolm, et al.
Magma (New York, N.Y.)|August 30, 2008
An illustration of the potential for mapping MRI/MRS parameters with genetic over-expression profiles in human prostate cancerRobert E Lenkinski, B Nicolas Bloch, Fangbing Liu, et al.
Pageof 30

Showing results (121-130 of 296) with videos related to

Sort By:
Pageof 30
International Journal of Molecular Sciences|August 6, 2020
NR2F6 as a Prognostic Biomarker in HNSCCLuise Klapper, Julika Ribbat-Idel, Patrick Kuppler, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 2013
Activation of invariant NK T cells in periodontitis lesionsMichael Nowak, Benjamin Krämer, Manuela Haupt, et al.
International Journal of Molecular Sciences|December 28, 2016
Implication of the Receptor Tyrosine Kinase AXL in Head and Neck Cancer ProgressionAnne von Mässenhausen, Johannes Brägelmann, Hannah Billig, et al.
Journal of Personalized Medicine|June 24, 2022
TRIM24 Expression as an Independent Biomarker for Prognosis and Tumor Recurrence in HNSCCLuise Klapper, Christian Idel, Patrick Kuppler, et al.
Histology and Histopathology|July 6, 2023
TRIM11 expression in non-small cell lung cancer is associated with poor prognosisChristiane Kuempers, Tobias Jagomast, Finn-Ole Paulsen, et al.
Rare Tumors|October 31, 2017
Mammary analogue secretory carcinoma of salivary glands: diagnostic pitfall with distinct immunohistochemical profile and molecular featuresOliver Bissinger, Carolin Götz, Andreas Kolk, et al.
Frontiers in Medicine|February 15, 2021
Immunologic "Cold" Squamous Cell Carcinomas of the Head and Neck Are Associated With an Unfavorable PrognosisJulika Ribbat-Idel, Sven Perner, Patrick Kuppler, et al.
International Journal of Molecular Sciences|August 6, 2020
CDK19 as a Potential HPV-Independent Biomarker for Recurrent Disease in HNSCCFinn-Ole Paulsen, Christian Idel, Julika Ribbat-Idel, et al.
Virchows Archiv : an International Journal of Pathology|December 2, 2019
Tumor budding as a prognostic factor in pancreatic ductal adenocarcinomaEkaterina Petrova, Verena Zielinski, Louisa Bolm, et al.
Magma (New York, N.Y.)|August 30, 2008
An illustration of the potential for mapping MRI/MRS parameters with genetic over-expression profiles in human prostate cancerRobert E Lenkinski, B Nicolas Bloch, Fangbing Liu, et al.
Pageof 30